We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$28B
1-Year Est. Return
44.22%
This Fund
S&P 500
This Quarter
Est. Return
+23.06%
1 Year Est. Return
+44.22%
3 Year Est. Return
+129.23%
5 Year Est. Return
+202.08%
10 Year Est. Return
–
AUM
$28B
AUM Growth
+$3.95B
(+16%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
4.46%
Top 10 Holdings %
Top 10 Hldgs %
30.24%
Holding
5,293
New
979
Increased
1,668
Reduced
1,868
Closed
619
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.75B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$642M |
| 3 |
JPMorgan Chase
JPM
|
+$204M |
| 4 |
Microsoft
MSFT
|
+$165M |
| 5 |
Cisco
CSCO
|
+$99.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.05B |
| 2 |
Amazon
AMZN
|
+$170M |
| 3 |
Airbnb
ABNB
|
+$115M |
| 4 |
NVIDIA
NVDA
|
+$112M |
| 5 |
ASML
ASML
|
+$87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.72% |
| 2 | Technology | 11.48% |
| 3 | Industrials | 7.26% |
| 4 | Financials | 7.22% |
| 5 | Consumer Discretionary | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Xeris Biopharma Holdings
XERS
$1.4B
| $4.84M | 0.02% |
+611,296
| New | +$3.9M |
|
802
PUT
Salesforce
CRM
$209B
| $4.84M | 0.02% |
30,900
-93,500
| -75% | -$16.4M |
|
803
Goodyear
GT
$1.51B
| $4.83M | 0.02% |
+731,716
| New | +$4.71M |
|
804
PUT
AT&T
T
$182B
| $4.82M | 0.02% |
233,000
-8,800
| -4% | -$218K |
|
805
CALL
KKR & Co
KKR
$89.7B
| $4.82M | 0.02% |
52,500
-2,600
| -5% | -$252K |
|
806
MoonLake Immunotherapeutics
MLTX
$1.03B
| $4.81M | 0.02% |
246,869
-73,603
| -23% | -$1.33M |
|
807
PUT
Royal Caribbean
RCL
$67.4B
| $4.79M | 0.02% |
15,100
+5,700
| +61% | +$1.59M |
|
808
MGM Resorts International
MGM
$9.78B
| $4.79M | 0.02% |
100,246
+89,859
| +865% | +$3.73M |
|
809
CALL
Rocket Lab Corp
RKLB
$40.7B
| $4.79M | 0.02% |
47,100
-24,400
| -34% | -$2.43M |
|
810
CALL
Baidu
BIDU
$30.4B
| $4.78M | 0.02% |
41,800
-35,800
| -46% | -$4.43M |
|
811
CALL
Ford
F
$53.3B
| $4.76M | 0.02% |
342,700
-144,800
| -30% | -$1.95M |
|
812
CALL
Nike
NKE
$54.1B
| $4.76M | 0.02% |
115,900
-14,700
| -11% | -$647K |
|
813
LyondellBasell Industries
LYB
$20.8B
| $4.75M | 0.02% |
90,286
+83,710
| +1,273% | +$5.78M |
|
814
CALL
Strategy Inc
MSTR
$50.4B
| $4.7M | 0.02% |
54,100
-14,300
| -21% | -$2.08M |
|
815
CALL
Boston Scientific
BSX
$64.3B
| $4.69M | 0.02% |
109,900
-2,100
| -2% | -$114K |
|
816
PUT
BP
BP
$119B
| $4.69M | 0.02% |
126,900
+76,200
| +150% | +$3.34M |
|
817
PUT
Cloudflare
NET
$118B
| $4.68M | 0.02% |
19,100
-1,800
| -9% | -$394K |
|
818
CALL
Kroger
KR
$36.7B
| $4.67M | 0.02% |
84,100
+40,600
| +93% | +$2.65M |
|
819
Emcor
EME
$32.6B
| $4.67M | 0.02% |
5,624
-1,285
| -19% | -$1.09M |
|
820
PUT
Thermo Fisher Scientific
TMO
$237B
| $4.66M | 0.02% |
9,300
+7,100
| +323% | +$3.41M |
|
821
GeneDx Holdings
WGS
$2.91B
| $4.66M | 0.02% |
+67,900
| New | +$3.86M |
|
822
PUT
CrowdStrike
CRWD
$247B
| $4.66M | 0.02% |
24,800
-50,000
| -67% | -$7.1M |
|
823
CALL
State Street
STT
$50.7B
| $4.65M | 0.02% |
27,400
+4,300
| +19% | +$663K |
|
824
Xenon Pharmaceuticals
XENE
$5.51B
| $4.65M | 0.02% |
+76,955
| New | +$4.27M |
|
|
DRUG
825
Bright Minds Biosciences
DRUG
$592M
| $4.64M | 0.02% |
66,106
+12,400
| +23% | +$974K |
|
Similar funds
CM
SSA
UIM
CAM
Walleye Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Walleye Capital held 5,293 positions worth $28B, up 16% from $24B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Walleye Capital deployed $1.25B of net new capital in Q2 2026, opening 979 new positions and adding to 1,668 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 ETF: 20,509,091 shares worth $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 59% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.05B trimmed.
- Walleye Capital's largest Q2 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 20,509,091 shares worth $1.8B.
- Walleye Capital added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $642M increase.
- Walleye Capital's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.05B.
- Walleye Capital fully exited Garmin in Q2 2026, selling an estimated $53.3M.
- Walleye Capital's ten largest holdings make up 30% of its $28B portfolio in Q2 2026.
- Walleye Capital opened 979 new positions and closed 619 in Q2 2026.
- Walleye Capital's portfolio value rose 16% quarter-over-quarter to $28B.
Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.